Targeting Stem Cells in Chronic Myeloid Leukemia with a PPAR-γ Agonist.
Where this comes from
- Record sourced from PubMed, PMID 26559576.
- Also identified by DOI 10.1056/NEJMcibr1511276.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Combining a tyrosine kinase inhibitor (imatinib) and a thiazolidinedione (pioglitazone) is proposed for the treatment of chronic myeloid leukemia.
Medical subject headings
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- PPAR gamma
- Protein Kinase Inhibitors